Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies. - Wikidata - awgldk - TriplyDB

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

http://www.wikidata.org/entity/Q37963451

about

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

http://www.wikidata.org/entity/Q37963451

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

@en

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

@nl

type

label

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

@en

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

@nl

prefLabel

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

@en

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

@nl

P1433

Q37963451-D1C6B725-BCAA-45CB-A298-C308F96034FB

P1476

Q37963451-5D76B2E2-4924-4144-9A43-BD0E5DC7E4B2

P2093

Q37963451-3BC2A443-2EBF-410B-830A-FF8092CFF4ED

P2860

Q37963451-11376FAA-C935-41F6-860B-89EA27A35DB6

Q37963451-16D0A75B-E194-4894-B015-21A7CAEF6B0B

Q37963451-1B8C1F82-F7B5-49F4-BB92-B06466DEC750

Q37963451-24F22E1E-AC23-47B3-84AF-7F7A84B116C7

Q37963451-2EFC17DB-2528-43FA-922C-000D940633B4

Q37963451-5F8F0CDC-0D6A-4147-8C3A-DD88524372D4

Q37963451-5FD9C637-9221-460B-B397-A86C746BD269

Q37963451-75049152-AEED-435F-A33A-6668385044BE

Q37963451-7982F532-B6FC-4335-B9F3-08CA9565F30D

Q37963451-7CD65389-9E75-49B3-8B63-E0510981D937

P304

Q37963451-16269AF3-7EE2-4670-A1B4-4C9F78D8525F

P31

Q37963451-24535A40-7D22-45C6-91CC-AF7938EE6CF9

P356

Q37963451-D3BDCAA7-E685-40EE-BB75-7A92503E0CAB

P407

Q37963451-5F7AD1DE-A742-4F04-A900-8A19215425C5

P433

Q37963451-DFFA3B1A-3E76-41BB-816F-7B535910A10F

P478

Q37963451-0DE47A47-79CA-42F7-A78B-521DB5AE2A9F

P577

Q37963451-FCB4E62F-1E69-43D9-AC39-7DD52A7B25F8

P698

Q37963451-E8A0F23A-957A-47D5-A4A4-1E94D963ADCA

P921

Q37963451-789E1404-35FD-4A20-B5D2-96F4D3529B94

Q37963451-8A762EEC-8AD4-4E5B-AF44-1433813FFD00

P356

07853890.2011.603701

P1433

Annals of Medicine

P1476

Saxagliptin for the treatment of type 2 diabetes mellitus: focus on recent studies.

@en

P2093

Sherwyn L Schwartz

http://www.w3.org/2001/XMLSchema#string

P2860

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes.

Efficacy and safety of saxagliptin in older patients with type 2 diabetes mellitus.

The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone

Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trial

Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone.

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.

Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus

Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus.

P304

157-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/07853890.2011.603701

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22132773

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes